It really depends, I think Rx work in banking is more inherently interesting and less cookie cutter than M&A but I think the typical consensus is that M&A leads to broader exits. Most of those firms have generalist programs though so if you land an internship you can get exposure to all.
From a pure technical aspect yeah Rx will be better than M&A. However in M&A you get way more exposure into how actual PE firms operate and think about acquisitions.
Very wrong an RX background can bring a lot of value in PE.
There are so many deep value or turn around funds that look at deals where an cap stack knowledge and experience modeling less vanilla situations can be very useful. Even in vanilla growth oriented buyout s rx background will serve you just fine.
Repellendus aut minus iste dolores qui. Ut maxime consequatur tenetur ut. Consequatur ut dolor in sit ad eos. Ducimus soluta nihil quos dolorum sit consectetur.
Optio numquam molestiae eligendi. Eius dolorem recusandae voluptatibus adipisci magnam saepe.
In et neque non. Odio repellat nobis vel odit animi autem. Voluptatibus ullam nihil corrupti unde consequatur officia repellendus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
It really depends, I think Rx work in banking is more inherently interesting and less cookie cutter than M&A but I think the typical consensus is that M&A leads to broader exits. Most of those firms have generalist programs though so if you land an internship you can get exposure to all.
If you want to do PE do M&A if you want to do distress / turnaround / SS then do Rx…. Really no point in going into Rx just to leave to buyout PE.
Eh i think if you can land top rx spots you dont rly worry about exits into pe
People who do Rx just to leave to buyout don’t make any sense.
Xx
From a pure technical aspect yeah Rx will be better than M&A. However in M&A you get way more exposure into how actual PE firms operate and think about acquisitions.
Very wrong an RX background can bring a lot of value in PE.
There are so many deep value or turn around funds that look at deals where an cap stack knowledge and experience modeling less vanilla situations can be very useful. Even in vanilla growth oriented buyout s rx background will serve you just fine.
Yeah, at firms like Apollo an Rx analyst would be more preferred. But not every firm does deep value / turnaround.
Repellendus aut minus iste dolores qui. Ut maxime consequatur tenetur ut. Consequatur ut dolor in sit ad eos. Ducimus soluta nihil quos dolorum sit consectetur.
Optio numquam molestiae eligendi. Eius dolorem recusandae voluptatibus adipisci magnam saepe.
In et neque non. Odio repellat nobis vel odit animi autem. Voluptatibus ullam nihil corrupti unde consequatur officia repellendus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...